Literature DB >> 26895218

Ambulatory Blood Pressure, Left Ventricular Hypertrophy, and Allograft Function in Children and Young Adults After Kidney Transplantation.

Gilad Hamdani1, Edward J Nehus, Coral D Hanevold, Judith Sebestyen Van Sickle, Robert Woroniecki, Scott E Wenderfer, David K Hooper, Douglas Blowey, Amy Wilson, Bradley A Warady, Mark M Mitsnefes.   

Abstract

BACKGROUND: Hypertension is a common complication and is an important risk factor for graft loss and adverse cardiovascular outcomes in pediatric kidney transplantation. Ambulatory blood pressure monitoring (ABPM) is the preferred method to characterize blood pressure status.
METHODS: We conducted a retrospective review of a large cohort of children and young adults with kidney transplant to estimate the prevalence of abnormal ambulatory blood pressure (ABP), assess factors associated with abnormal ABP, and examine whether ambulatory hypertension is associated with worse allograft function and left ventricular hypertrophy (LVH).
RESULTS: Two hundred twenty-one patients had ABPM, and 142 patients had echocardiographic results available for analysis. One third of the patients had masked hypertension, 32% had LVH, and 38% had estimated glomerular filtration rate less than 60 mL/min per 1.73 m. African-American race/Hispanic ethnicity and requirement for more than 1 antihypertensive medication were independently associated with having masked hypertension. In a multivariate analysis, abnormal blood pressure (masked or sustained hypertension combined) was an independent predictor for LVH among patients not receiving antihypertensive treatment (P = 0.025). In a separate analysis, the use of antihypertensive medications was independently associated with worse allograft function (P = 0.002) although abnormal blood pressure was not a significant predictor.
CONCLUSIONS: In young kidney transplant recipients, elevated ABP is frequently unrecognized and undertreated. The high prevalence of abnormal ABP, including masked hypertension, and its association with LVH supports the case for routine ABPM and cardiac structure evaluation as the standard of care in these patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 26895218      PMCID: PMC4990501          DOI: 10.1097/TP.0000000000001087

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  35 in total

1.  Post-transplant hypertension in pediatric kidney transplant recipients.

Authors:  Bora Gülhan; Rezan Topaloğlu; Erdem Karabulut; Fatih Ozaltın; Fazıl Tuncay Aki; Yelda Bilginer; Nesrin Beşbaş
Journal:  Pediatr Nephrol       Date:  2014-01-04       Impact factor: 3.714

2.  Control of hypertension in children after renal transplantation.

Authors:  Tomás Seeman; Eva Simková; Jirí Kreisinger; Karel Vondrák; Jirí Dusek; Jirí Gilík; Janusz Feber; Pavel Dvorák; Jan Janda
Journal:  Pediatr Transplant       Date:  2006-05

3.  Systemic arterial hypertension in children following renal transplantation: prevalence and risk factors.

Authors:  Manish D Sinha; Larissa Kerecuk; Julie Gilg; Christopher J D Reid
Journal:  Nephrol Dial Transplant       Date:  2012-02-10       Impact factor: 5.992

4.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

5.  Hypertension, antihypertensive agents and outcomes following renal transplantation.

Authors:  V K Tutone; P B Mark; G A Stewart; C C Tan; R S C Rodger; C C Geddes; A G Jardine
Journal:  Clin Transplant       Date:  2005-04       Impact factor: 2.863

6.  Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.

Authors:  Mark M Mitsnefes; Philip R Khoury; Paul T McEnery
Journal:  J Pediatr       Date:  2003-07       Impact factor: 4.406

7.  Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study.

Authors:  Roberto Minutolo; Francis B Gabbai; Rajiv Agarwal; Paolo Chiodini; Silvio Borrelli; Vincenzo Bellizzi; Felice Nappi; Giovanna Stanzione; Giuseppe Conte; Luca De Nicola
Journal:  Am J Kidney Dis       Date:  2014-07-28       Impact factor: 8.860

8.  Strict blood-pressure control and progression of renal failure in children.

Authors:  Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

9.  Blood pressure profiles 5 to 10 years after transplant in pediatric solid organ recipients.

Authors:  Juuso Tainio; Erik Qvist; Jenni Miettinen; Tuula Hölttä; Mikko Pakarinen; Timo Jahnukainen; Hannu Jalanko
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-05       Impact factor: 3.738

10.  Racial and ethnic disparities in pediatric renal allograft survival in the United States.

Authors:  Rachel E Patzer; Sumit Mohan; Nancy Kutner; William M McClellan; Sandra Amaral
Journal:  Kidney Int       Date:  2014-10-22       Impact factor: 10.612

View more
  17 in total

1.  Non-immunologic allograft loss in pediatric kidney transplant recipients.

Authors:  Isa F Ashoor; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

2.  Is Blood Pressure Improving in Children With Chronic Kidney Disease? A Period Analysis.

Authors:  Gina-Marie Barletta; Christopher Pierce; Mark Mitsnefes; Joshua Samuels; Bradley A Warady; Susan Furth; Joseph Flynn
Journal:  Hypertension       Date:  2018-01-02       Impact factor: 10.190

3.  Secular Trends in Survival Outcomes of Kidney Transplantation for Children: Is the Future Bright Enough?

Authors:  Sandra Amaral
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

4.  Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children.

Authors:  Pauline Lancia; Beate Aurich; Phuong Ha; Anne Maisin; Véronique Baudouin; Evelyne Jacqz-Aigrain
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

Review 5.  Ambulatory Blood Pressure Monitoring in Children and Adolescents: a Review of Recent Literature and New Guidelines.

Authors:  Ian Macumber
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369

6.  The Improving Renal Outcomes Collaborative: Blood Pressure Measurement in Transplant Recipients.

Authors:  Michael E Seifert; Devesh S Dahale; Margret Kamel; Pamela D Winterberg; Gina-Marie Barletta; Craig W Belsha; Abanti Chaudhuri; Joseph T Flynn; Rouba Garro; Roshan P George; Jens W Goebel; David B Kershaw; Debora Matossian; Jason Misurac; Corina Nailescu; Christina R Nguyen; Meghan Pearl; Ari Pollack; Cozumel S Pruette; Pamela Singer; Judith S VanSickle; Priya Verghese; Bradley A Warady; Andrew Warmin; Patricia L Weng; Larysa Wickman; Amy C Wilson; David K Hooper
Journal:  Pediatrics       Date:  2020-06-09       Impact factor: 7.124

7.  Ambulatory Blood Pressure Control in Children and Young Adults After Kidney Transplantation.

Authors:  Gilad Hamdani; Edward J Nehus; Coral D Hanevold; Judith S VanSickle; David K Hooper; Doug Blowey; Bradley A Warady; Mark M Mitsnefes
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

Review 8.  Management of dyslipidemia in pediatric renal transplant recipients.

Authors:  Margret E Bock; Leslie Wall; Carly Dobrec; Mary Chandran; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2020-01-02       Impact factor: 3.714

9.  Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension?

Authors:  Tomáš Seeman; Janusz Feber
Journal:  Pediatr Nephrol       Date:  2020-02-14       Impact factor: 3.714

Review 10.  Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients.

Authors:  John G Rizk; Jose G Lazo; David Quan; Steven Gabardi; Youssef Rizk; Elani Streja; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Rev Endocr Metab Disord       Date:  2021-07-22       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.